Publicaties
Visceral leishmaniasis IgG1 rapid monitoring of cure vs. relapse, and potential for diagnosis of post kala-azar dermal leishmaniasis Instituut voor Tropische Geneeskunde Vrije Universiteit Brussel Universiteit Antwerpen
Background: There is a recognized need for an improved diagnostic test to assess post-chemotherapeutic treatment outcome in visceral leishmaniasis (VL) and to diagnose post kala-azar dermal leishmaniasis (PKDL). We previously demonstrated by ELISA and a prototype novel rapid diagnostic test (RDT), that high anti-Leishmania IgG1 is associated with post-treatment relapse versus cure in VL.
Methodology: Here, we further evaluate this ...
Drug susceptibility in Leishmania isolates following miltefosine treatment in cases of visceral leishmaniasis and post Kala azar dermal leishmaniasis Instituut voor Tropische Geneeskunde
Epidemiological study of canine leishmaniasis in Algeria and its impact on the human visceral leishmaniasis Instituut voor Tropische Geneeskunde
Leishmaniasis in the Sudan. II. Field evaluation of the direct agglutination test kit for the routine diagnosis of visceral leishmaniasis (DAT-VL Kit) in Gedaref area, Eastern Sudan; preliminary results Instituut voor Tropische Geneeskunde
Drug susceptibility in Leishmania isolates following miltefosine treatment in cases of visceral leishmaniasis and post Kala-azar dermal leishmaniasis Universiteit Antwerpen
Recurrence of visceral and muco-cutaneous leishmaniasis in a patient under immunosuppressive therapy Instituut voor Tropische Geneeskunde
Background: Leishmaniasis is a protozoan disease caused by parasites of the genus Leishmania, transmitted to humans by sandflies. The diagnosis of leishmaniasis is often challenging as it mimics many other infectious or malignant diseases. The disease can present in three ways: cutaneous, mucocutaneous, or visceral leishmaniasis, which rarely occur together or consecutively.
Case presentation: The patient was a 52 years old ...